TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 124 of 158 • 3,936 articles
Getty Images and Perplexity strike multi-year image partnership
GlobeNewswire Inc. • Not Specified
Getty Images and Perplexity strike multi-year image partnership

10/31/2025 08:00 AM • Getty Images and Perplexity have signed a global multi-year licensing agreement allowing Perplexity to display Getty Images' content across its AI-powered search tools, with a focus on proper image attribution and creator recognition.

GETY - Expanding content distribution, establishing strategic partnership with AI platform, emphasizing creator rights and proper attribution
#AI #licensing #image attribution #search engine #content partnership
Read More
Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc. • Todd Waltz
Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025

10/31/2025 08:00 AM • Aemetis, a renewable natural gas and renewable fuel company, will host its Q3 2025 earnings conference call on November 6, 2025, discussing its operations in California and India, including ethanol production and sustainable fuel development.

AMTX - Company is expanding renewable energy operations, developing sustainable fuel technologies, and demonstrating carbon intensity reduction across multiple facilities
#renewable natural gas #ethanol #sustainable aviation fuel #carbon intensity reduction
Read More
Blaqclouds Announces the Launch of Deploytokens.com — Multi-Chain Token Creation Powered by Apollo Wallet
GlobeNewswire Inc. • Shannon Hill
Blaqclouds Announces the Launch of Deploytokens.com — Multi-Chain Token Creation Powered by Apollo Wallet

10/31/2025 08:00 AM • Blaqclouds launched DeployTokens.com, a no-code token creation platform enabling users to design and deploy tokens across 20+ blockchains, integrated with Apollo Wallet for seamless multi-chain token management.

BCDS - Company is expanding its Web3 infrastructure with an innovative, user-friendly token creation platform that simplifies blockchain technology access
#Web3 #blockchain #token creation #multi-chain #cryptocurrency #decentralization
Read More
Aspen Group Reports Second Consecutive Quarter of Net Income for First Quarter Fiscal 2026
GlobeNewswire Inc. • Michael Mathews, Chairman And Ceo
Aspen Group Reports Second Consecutive Quarter of Net Income for First Quarter Fiscal 2026

10/31/2025 08:00 AM • Aspen Group reported a second consecutive quarter of net income at $0.4 million, with revenue increasing to $11.4 million. The company implemented cost controls, achieved positive operating cash flow, and saw growth primarily from United States University.

ASPU - Demonstrated positive net income, increased revenue, implemented successful cost control measures, and maintained positive operating cash flow
#education technology #online university #financial results #cost reduction #student enrollment
Read More
Upexi to Participate in Upcoming November Investor Conferences
GlobeNewswire Inc. • Brian Rudick
Upexi to Participate in Upcoming November Investor Conferences

10/31/2025 08:00 AM • Upexi, a digital asset treasury company focused on Solana, will participate in multiple investor conferences in November 2025, including events in New Orleans, Miami, New York City, and Palm Beach, featuring presentations and panel discussions on digital assets and cryptocurrency.

UPXI - Company is actively engaging with investors through multiple conferences, showcasing strategic positioning in digital asset treasury and demonstrating proactive investor relations
#Solana #digital asset #cryptocurrency #investor conferences #blockchain
Read More
Sow Good to Hold Third Quarter 2025 Conference Call on Friday, November 14, 2025 at 10:00 a.m. ET
GlobeNewswire Inc. • Sow Good Inc.
Sow Good to Hold Third Quarter 2025 Conference Call on Friday, November 14, 2025 at 10:00 a.m. ET

10/31/2025 08:00 AM • Sow Good Inc. will host a conference call on November 14, 2025, at 10:00 a.m. Eastern time to discuss its third quarter financial results for the period ended September 30, 2025.

SOWG - The article is a standard conference call announcement providing routine financial communication, with no explicit positive or negative indicators about the company's performance
#conference call #financial results #Q3 2025 #freeze dried candy
Read More
Certara to Participate in Upcoming Investor Conferences
GlobeNewswire Inc. • Certara, Inc.
Certara to Participate in Upcoming Investor Conferences

10/31/2025 08:00 AM • Certara launches AI-powered Quantitative Systems Pharmacology (QSP) platform called Certara IQ, highlighting the company's technological innovation in drug development. The company also celebrates its scientific achievements with 200 published papers and 11 scientists recognized among top cited researchers.

CERT - Company demonstrates technological innovation with new AI platform, highlights scientific achievements, and shows strong research credentials through published papers and top-cited researchers
#biosimulation #AI #drug development #QSP #pharmaceutical research
Read More
HOLDCO ASSET MANAGEMENT ISSUES PUBLIC PRESENTATION TO THE BOARD OF DIRECTORS OF EASTERN BANKSHARES, INC.
Benzinga • Prnewswire
HOLDCO ASSET MANAGEMENT ISSUES PUBLIC PRESENTATION TO THE BOARD OF DIRECTORS OF EASTERN BANKSHARES, INC.

10/31/2025 07:30 AM • HoldCo Asset Management, a Florida-based investment firm managing $2.6 billion in assets, issued a public presentation to Eastern Bankshares' Independent Board of Directors, disclosing its ownership of the company's common stock.

EBC - The presentation appears to be an informative communication about the company's stock, without explicitly positive or negative language. HoldCo owns common stock and is providing a perspective on the company's direction.
#investment #asset management #board presentation #shareholder interest
Read More
Agnico Eagle Reports Strong Q3, Forms A Critical Minerals Subsidiary
Benzinga • Stjepan Kalinic
Agnico Eagle Reports Strong Q3, Forms A Critical Minerals Subsidiary

10/31/2025 07:27 AM • Agnico Eagle Mines reported robust Q3 results with net income of $1.06 billion, strong gold production of 866,936 ounces, and created a new subsidiary called Avenir Minerals to manage critical mineral investments.

ALT - Mentioned as a key player in biodefense market without specific recent developments
AEM - Strong quarterly financial performance, record net income, robust gold production, low costs, high gold prices, and strategic creation of a new subsidiary
#gold mining #critical minerals #earnings #production #subsidiary
Read More
Amazon, Google, Beyond Meat— Investors Couldn't Stop Talking About These And More Stocks This Week
Benzinga • Rishabh Mishra
Amazon, Google, Beyond Meat— Investors Couldn't Stop Talking About These And More Stocks This Week

10/31/2025 07:22 AM • Retail investors focused on five key stocks during the week, driven by earnings reports, AI developments, and market speculation across tech, food, and internet sectors.

EBS - Listed as a key market player without specific positive or negative indicators
AMZN - Strong Q3 earnings with $180.2B revenue, 38% profit growth, AWS surge, and raised $125B AI infrastructure capex forecast
#earnings #AI #retail investors #stock market #tech stocks
Read More
Will BigBear.ai Reach $10 in 2026?
The Motley Fool • Keithen Drury
Will BigBear.ai Reach $10 in 2026?

10/31/2025 07:15 AM • BigBear.ai, an AI solutions provider for government clients, faces challenges in reaching $10 per share by 2026 due to low gross margins, limited market potential, and declining revenue growth.

BVNRY - Listed as a key market player without specific positive or negative indicators
BBAI - Low gross margins (20-30% vs industry 70-90%), declining revenue, limited market scalability, and lack of profitability
#AI #government contracts #software solutions #stock analysis
Read More
Toyota, Nissan May Import US-Made Cars To Japan To Woo Trump: Report
Benzinga • Badar Shaikh
Toyota, Nissan May Import US-Made Cars To Japan To Woo Trump: Report

10/31/2025 07:09 AM • Japanese automakers Toyota and Nissan are considering importing US-made vehicles to Japan as a diplomatic gesture to reduce trade tensions with the Trump administration, despite significant technical challenges like different driving configurations.

TM - Exploring strategic diplomatic import option to manage trade relations, with potential challenges in vehicle adaptation
#trade tensions #imports #automotive #US-Japan relations #Trump administration
Read More
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
GlobeNewswire Inc. • Regeneron Pharmaceuticals
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award

10/31/2025 07:00 AM • Regeneron's Dupixent was recognized as the 'Best Biotechnology Product' of 2025 by the Galien Foundation, highlighting its groundbreaking approach to treating multiple allergic and inflammatory conditions by targeting IL-4 and IL-13 signaling pathways.

GOOG - Briefly mentioned in passing without substantive discussion
REGN - Company received prestigious industry award, demonstrated scientific innovation, and highlighted successful drug development with over 1 million patients treated globally
#biotechnology #immunology #drug development #inflammation #allergic conditions
Read More
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
GlobeNewswire Inc. • Amicus Therapeutics
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025

10/31/2025 07:00 AM • Amicus Therapeutics will participate in two healthcare investor conferences in November 2025, presenting at UBS Global Healthcare Conference and Jefferies Global Healthcare Conference, with live audio webcasts available.

FOLD - Company is actively engaging with investors through conference presentations, demonstrating transparency and confidence in its business strategy and potential growth
#investor conferences #healthcare #biotechnology #webcast
Read More
Upstream Bio to Participate in Upcoming November Investor Conferences
GlobeNewswire Inc. • Meggan Buckwell
Upstream Bio to Participate in Upcoming November Investor Conferences

10/31/2025 07:00 AM • Upstream Bio, a clinical-stage biotechnology company, will participate in multiple investor conferences in November 2025, presenting its research on verekitug, a potential treatment for inflammatory respiratory diseases.

UPB - Company is actively presenting at multiple investor conferences, showcasing ongoing clinical development of a novel therapeutic approach for inflammatory respiratory diseases
#biotechnology #inflammatory diseases #respiratory disorders #investor conferences #verekitug
Read More
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
GlobeNewswire Inc. • Adagene Inc.
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

10/31/2025 07:00 AM • Adagene initiated a Phase 2 clinical trial for muzastotug (ADG126) in combination with KEYTRUDA for microsatellite stable colorectal cancer, randomizing patients to 10 or 20 mg/kg doses with anticipated trial completion in early 2027.

ADAG - Advancing clinical trial, positive preliminary data, FDA alignment, and potential for novel cancer therapy
#clinical trial #oncology #immunotherapy #colorectal cancer #muzastotug
Read More
Mesa Air Group enters into an Amendment to its Loan Agreement with the United States Treasury and Provides Update to its Pending Merger with Republic Airways
GlobeNewswire Inc. • Mesa Air Group, Inc.
Mesa Air Group enters into an Amendment to its Loan Agreement with the United States Treasury and Provides Update to its Pending Merger with Republic Airways

10/31/2025 07:00 AM • Mesa Air Group amended its Treasury loan agreement, extending maturity and reducing interest, while preparing for a merger with Republic Airways that would create a regional airline with estimated $1.8-2.0 billion annual revenue.

MESA - Secured loan amendment with favorable terms, progressing towards merger with strong projected financials and potential stockholder value
#merger #loan amendment #regional airline #United Airlines #capacity purchase agreement
Read More
Perspective Therapeutics to Participate in Upcoming November Conferences
GlobeNewswire Inc. • Perspective Therapeutics, Inc.
Perspective Therapeutics to Participate in Upcoming November Conferences

10/31/2025 07:00 AM • Radiopharmaceutical company Perspective Therapeutics will participate in upcoming investor conferences, showcasing its advanced cancer treatment technology utilizing alpha-emitting isotope 212Pb for targeted radiation therapy.

CATX - Company is presenting at multiple investor conferences, highlighting ongoing clinical trials, developing innovative cancer treatment technology, and expanding its drug product candidate facilities
#radiopharmaceuticals #cancer treatment #alpha-emitting isotope #theranostic approach #clinical trials
Read More
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
GlobeNewswire Inc. • Biostem Technologies
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

10/31/2025 07:00 AM • BioStem Technologies announced successful clinical trial results for its BioRetain® allograft in treating diabetic foot ulcers, demonstrating a 53% healing probability compared to 31% with standard care.

BSEM - Reported superior clinical trial results showing significant improvement in wound healing, highlighting potential commercial and medical value of their BioRetain® technology
#diabetic foot ulcers #wound care #clinical trial #allograft #medical technology
Read More
Prediction: This Stock Will Be the Ultimate Quantum Computing Winner
The Motley Fool • Keithen Drury
Prediction: This Stock Will Be the Ultimate Quantum Computing Winner

10/31/2025 06:30 AM • Alphabet is predicted to be the ultimate quantum computing winner due to its significant technological breakthroughs, substantial financial resources, and ability to develop quantum computing technologies in-house without the existential risks faced by pure-play quantum computing companies.

GOOGL - Briefly mentioned in passing without substantive discussion
GOOG - The article highlights Alphabet's quantum computing advancements, including completing tasks 13,000 times faster than supercomputers, having substantial financial resources, and being well-positioned to develop quantum technologies without the risks of pure-play competitors
#quantum computing #technology #investment #Alphabet #Google
Read More
US-India Sign 10-Year Defense Pact For Regional Stability: 'Ties Have Never Been Stronger'
Benzinga • Namrata Sen
US-India Sign 10-Year Defense Pact For Regional Stability: 'Ties Have Never Been Stronger'

10/31/2025 06:25 AM • India and the U.S. have signed a 10-year defense framework agreement to enhance coordination, information sharing, and technology cooperation, aimed at promoting regional stability in the Indo-Pacific region.

NVDA - Briefly mentioned in passing without substantive discussion
LMT - Potential beneficiary of increased military equipment sales between U.S. and India, with discussions about potential F-35 stealth warplane sales
#defense cooperation #regional stability #Indo-Pacific #military partnership #trade
Read More
Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030
Benzinga • Neeraj Chawla
Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030

10/31/2025 06:19 AM • Kuick Research released a comprehensive study on the US Orphan Drug Market, projecting market opportunities exceeding $190 billion by 2030, with over 850 orphan drugs in clinical trials and 500 marketed orphan drugs, highlighting significant investment potential in rare disease therapeutics.

ORCL - Briefly mentioned in passing without substantive discussion
MRK - Keytruda generated nearly $29.4 billion in global revenue in 2024, demonstrating successful expansion from an orphan drug designation to a blockbuster therapeutic
#orphan drugs #rare disease #pharmaceutical investment #FDA #biotechnology
Read More
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
The Motley Fool • David Jagielski
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?

10/31/2025 06:15 AM • Recursion Pharmaceuticals uses AI for drug discovery, aiming to reduce drug development time and costs. Despite ambitious claims, the company faces significant financial challenges, including substantial losses and ongoing cash burn.

RXRX - High cash losses ($649.1M), no late-stage drug trials, rising share count, declining stock price, and unproven technology make the investment risky
#AI #drug discovery #pharmaceutical #artificial intelligence #healthcare innovation
Read More
Why Smurfit Westrock Stock Was Sliding This Week
The Motley Fool • Eric Volkman
Why Smurfit Westrock Stock Was Sliding This Week

10/31/2025 06:09 AM • Smurfit Westrock reported Q3 earnings with net sales of $8 billion, a 4% year-over-year increase, but missed analyst expectations on adjusted net income, causing stock price decline.

SW - Missed analyst earnings expectations of $0.72 per share, reporting only $0.58, with CEO describing 2025 as having a 'challenging demand backdrop'. Stock price dropped over 16% week-to-date and analysts lowered price targets.
#packaging #earnings #stock performance #Q3 results
Read More
Dow Theory: A Concerning Divergence or Artifact?
Investing.com • Michael Lebowitz
Dow Theory: A Concerning Divergence or Artifact?

10/31/2025 06:07 AM • The article explores potential market warning signs through Dow Theory, highlighting divergences in transportation indices, trucking demand, and significant performance gaps between market-cap-weighted and equal-weighted S&P 500 indexes.

META - Shares fell nearly 10% despite revenue beat, with concerns about significant CapEx spending in AI and potential market worry about overinvestment
#Dow Theory #Transportation Index #Market Divergence #S&P 500 #Trucking Demand
Read More